Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12
Developed to target the cytosolic enzyme nicotinamide N-methyltransferase (NNMT), 5-Amino-1MQ serves as a highly specialized molecular probe designed to study the regulation of energy homeostasis, macromolecular metabolism, and epigenetic signaling networks within mammalian tissue models, particularly white adipose tissue (WAT)
Avoid vigorous agitation, which may compromise peptide integrity
Stream NBC4 newscasts for free right here, right now
Every order automatically gets 15% off , and the savings increase as you buy more: 18% off when you purchase 6+ vials and 20% off at 8+ vials
Others Key Target Audience Market Players Investors End-users Government Authorities Consulting and Research Firm Venture capitalists Value-Added Resellers (VARs) Recent Development In March 2026, UroGen Pharma reported strong momentum following the FDA approval and commercial launch of ZUSDURI, the first approved treatment for recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer
( Unfortunately, this symptom of B12 deficiency overlaps with symptoms related to diabetic neuropathy nerve damage caused by high blood sugar that can cause pain and numbness in the extremities ( People with diabetes taking metformin are at a higher risk of developing B12 deficiency because this medication can reduce vitamin B12 absorption in the body ( So, a B12 deficiency could be misdiagnosed as peripheral neuropathy in people with diabetes
